Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jul;36(7):2093-5.
doi: 10.1128/JCM.36.7.2093-2095.1998.

Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans

E Pinjon  1 , D Sullivan, I Salkin, D Shanley, D Coleman
Affiliations

Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans

E Pinjon et al. J Clin Microbiol. 1998 Jul.

Abstract

Candida dubliniensis is a recently described pathogenic species which shares many phenotypic features with Candida albicans, including the ability to form germ tubes and chlamydospores. These similarities have caused significant problems in the identification of C. dubliniensis by the average clinical mycology laboratory. To facilitate the differentiation of these species, we investigated the growth of 120 isolates of C. dubliniensis and 98 C. albicans isolates at 42 and 45 degrees C on Emmons' modified Sabouraud glucose agar (SGA) and 10 isolates of each species in yeast-peptone-dextrose broth. None of the C. dubliniensis isolates grew on the agar or in the broth medium at 45 degrees C, while 11 isolates were capable of growing on SGA at 42 degrees C. In contrast, all of the C. albicans isolates but one grew at 45 degrees C on or in either medium. These reproducible results clearly demonstrate that the incubation of isolates suspected to be C. dubliniensis or C. albicans at 45 degrees C provides a simple, reliable, and inexpensive method for the differentiation of the two species.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Growth curves of the oral isolates C. albicans 132A and CA58.1 and C. dubliniensis CD36 and CD43 in YPD broth medium at 37°C (solid lines) and 45°C (dashed lines). O.D. 600, optical density at 600 nm.
See this image and copyright information in PMC

References

    1. Boerlin P, Boerlin-Petzold F, Durussel C, Addo M, Pagani J-L, Chave J-P, Bille J. Cluster of oral atypical Candida isolates in a group of human immunodeficiency virus-positive drug users. J Clin Microbiol. 1995;33:1129–1135. - PMC - PubMed
    1. Coleman, D., D. Sullivan, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, L. O’Neill, and B. Harrington. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3(Suppl. 1):S96–S101. - PubMed
    1. Coleman D C, Sullivan D J, Bennett D E, Moran G P, Barry H J, Shanley D B. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS. 1997;11:557–567. - PubMed
    1. McCullough M J, Ross B C, Dwyer B D, Reade P C. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology. 1994;140:1195–1202. - PubMed
    1. Moran G P, Sullivan D J, Henman M C, McCreary C E, Harrington B J, Shanley D B, Coleman D C. Antifungal drug susceptibility of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother. 1997;41:617–623. - PMC - PubMed

Publication types

LinkOut - more resources